Hemmi K, Aratani M, Takeno H, Okada S, Miyazaki Y, Nakaguchi O, Kitaura Y, Hashimoto M
J Antibiot (Tokyo). 1982 Oct;35(10):1300-11. doi: 10.7164/antibiotics.35.1300.
For the structural confirmation of FK-156, two possible structures, 1 and its geometric isomer 2, were synthesized. Di-Z-meso-diaminopimelic acid (4) was converted into 14 via a sequence of reactions involving, as key steps, an enzyme-mediated asymmetric hydrolysis (6 leads to 7), followed by carbobenzyloxylation using a copper chelate procedure (7 leads to 8). Condensation of 14 and the appropriately protected lactoyl dipeptide 17 and removal of the protecting groups of the resulting 18 afforded 1. Protection of 7 to 22, followed by coupling to glycine via an azide method, gave 25. Derivatization of 25 to 29 and condensation with 17 gave 30, which was deprotected to yield 2. Compound 1 proved to be identical in all respects with the natural product.
为了对FK-156进行结构确证,合成了两种可能的结构,即1及其几何异构体2。通过一系列反应将二-Z-内消旋-二氨基庚二酸(4)转化为14,其中关键步骤包括酶介导的不对称水解(6生成7),随后采用铜螯合程序进行苄氧羰基化(7生成8)。14与适当保护的乳酰二肽17缩合,并去除所得产物18的保护基团,得到1。将7保护为22,然后通过叠氮法与甘氨酸偶联,得到25。将25衍生化为29并与17缩合,得到30,对其进行脱保护得到2。化合物1在所有方面均被证明与天然产物相同。